This class proceeding concerns allegations that Biomet, Inc. and related companies were negligent in the research, design, manufacture, regulatory licensing, sale and post-market monitoring of the M2a Magnum, the M2a 38, and the ReCap Femoral Resurfacing System metal-on-metal hip implants.
A metal-on-metal hip implant is one in which both the ball and socket of the product are made of metal. Despite serious and numerous reports of failure of the Biomet implants and an unacceptably high early revision rates and other problems, no warning was provided to Canadian patients of the significant risk of failure of the Biomet implants, and Biomet continues to market and distribute the Biomet metal-on-metal implants in Canada.
If you have received a Biomet hip implant, please call 1-855-595-2629 or email biometclassaction@kmlaw.ca.